Home

ADRIAN ADAMS

CIK 1248144 · COB, CEO and President · last filed 2026-06-24

ADRIAN ADAMS is a COB, CEO and President who has filed 63 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for TLPH, was dated Jun 24, 2026. Across all open-market trades the lifetime net is +$8.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $329.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$329.5K

Companies

10

Total Filings

63

Lifetime Open-Market Net

$8.54M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TLPH Director 22,709 $1.30 $29.5K $0 3 2026-06-24
AKBA Director 236,200 $1.27 $300.0K $170.5K 10 2026-06-22
TALPHERA, INC. (ACRX) Delisted Director 11,168 $0.86 $9.6K $614.0K 15 2023-12-13
IPI Legacy Liquidation Co (IMPL) Delisted COB, CEO and President 17,203 $0.24 $4.1K $279.8K 4 2023-02-16
Aralez Pharmaceuticals Inc. (ARLZ) Delisted Chief Executive Officer 3,787,610 — — $1.23M 4 2017-05-12
POZEN INC /NC (POZN) Delisted Chief Executive Officer 2,496,359 — — $6.55M 2 2015-11-12
AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted CEO and President 120,134 — — -$1.36M 7 2015-01-30
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Director 21,000 — — $0 6 2012-05-17
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted President and CEO 0 — — $0 4 2011-05-16
SEPRACOR INC /DE/ (SEPR) Delisted President & CEO 241,667 — — $1.05M 5 2009-10-19

Recent Filings

63 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-24 TLPH Grant (A) +5,100 $0 EDGAR
2026-06-22 AKBA Grant (A) +35,700 $0 EDGAR
2025-10-24 TLPH Grant (A) +4,267 $0 EDGAR
2025-06-11 AKBA Grant (A) +35,700 $0 EDGAR
2024-06-24 TLPH Grant (A) +2,174 $0 EDGAR
2024-06-10 AKBA Grant (A) +30,000 $0 EDGAR
2023-12-13 TALPHERA, INC. (ACRX) Delisted Grant (A) +581 $0 EDGAR
2023-06-08 AKBA Grant (A) +30,000 $0 EDGAR
2023-02-16 IPI Legacy Liquidation Co (IMPL) Delisted Grant (A) — $0 EDGAR
2022-07-15 TALPHERA, INC. (ACRX) Delisted Grant (A) +15,500 $0 EDGAR
Showing 1–10 of 63
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.